Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
WELL Health TechnologiesWHTCF 74 Intrinsic Value: Projected FCF is $3.64 as of Sep. 04, 2026. GuruFocus rates WHTCF with a GF Score™ of 74/100 and a GF Value™ of $5.15 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 342 Healthcare Providers & Services companies, WELL Health Technologies ranks better than 63.74% on this metric.
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.
The historical rank and industry rank for WELL Health Technologies's Intrinsic Value: Projected FCF or its related term are showing as below:
WHTCF'
s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 0.78 Med: 1.65 Max: 38.5
Current: 0.85
During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of WELL Health Technologies was 38.50. The lowest was 0.78. And the median was 1.65.
WHTCF's Price-to-Projected-FCF is ranked better than 63.74% of 342
companies
in the Healthcare Providers & Services industry
Industry Median: 1.075
vs WHTCF: 0.85
WELL Health Technologies (OTCPK:WHTCF) Intrinsic Value: Projected FCF Explanation
The growth multiple is capped between 8.35 and 17.74.
Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.
WELL Health Technologies's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as
Price-to-Intrinsic-Value-Projected-FCF
=
Share Price
/
Intrinsic Value: Projected FCF
=
3.095
/
3.6392082811671
=
0.85
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WELL Health Technologies Intrinsic Value: Projected FCF Related Terms
WELL Health Technologies Intrinsic Value: Projected FCF Historical Data
* Premium members only.
The historical data trend for WELL Health Technologies's Intrinsic Value: Projected FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WELL Health Technologies Intrinsic Value: Projected FCF Chart
WHTCF vs HCA, THC, EHC: Intrinsic Value: Projected FCF Comparison
For the Medical Care Facilities subindustry, WELL Health Technologies's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
WELL Health Technologies Price-to-Projected-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, WELL Health Technologies's Price-to-Projected-FCF distribution charts can be found below:
* The bar in red indicates where WELL Health Technologies's Price-to-Projected-FCF falls into.
WELL Health Technologies Intrinsic Value: Projected FCF Calculation
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.
The details of how we calculate the intrinsic value of stocks are described in detail here.
This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Intrinsic Value: Projected FCF of $3.64 mean?
WELL Health Technologies (WHTCF) has a Intrinsic Value: Projected FCF of $3.64 as of Sep. 04, 2026. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on WELL Health Technologies and its competitors. According to the industry distribution chart, WELL Health Technologies ranks #124 out of 342 companies in the Healthcare Providers & Services industry, placing it in the top 36.3%.
Is WELL Health Technologies' Intrinsic Value: Projected FCF too high?
WELL Health Technologies' current Intrinsic Value: Projected FCF is $3.64. The Healthcare Providers & Services industry median Intrinsic Value: Projected FCF is 1.08. WELL Health Technologies' value of $3.64 is 238.6% above this industry median. Based on the distribution chart, WELL Health Technologies ranks #124 out of 342 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, WELL Health Technologies has a GF Score™ of 74/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does WELL Health Technologies' Intrinsic Value: Projected FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, WELL Health Technologies ranks #124 out of 342 companies for Intrinsic Value: Projected FCF. This puts WELL Health Technologies in the upper half of its industry. The industry median Intrinsic Value: Projected FCF is 1.08. WELL Health Technologies' value of $3.64 is 238.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Intrinsic Value: Projected FCF for a Healthcare Providers & Services company?
The median Intrinsic Value: Projected FCF among Healthcare Providers & Services companies is 1.08, based on 342 companies in the industry. Companies in the top quartile (top 25%) have a Intrinsic Value: Projected FCF significantly above this median, while those in the bottom quartile fall well below. However, Intrinsic Value: Projected FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. WELL Health Technologies's current Intrinsic Value: Projected FCF of $3.64 is 238.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Intrinsic Value: Projected FCF mean?
A high Intrinsic Value: Projected FCF can signal that a stock is expensive relative to its fundamentals. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on WELL Health Technologies and its competitors. For the Healthcare Providers & Services industry, the median Intrinsic Value: Projected FCF is 1.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. WELL Health Technologies's current Intrinsic Value: Projected FCF is $3.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is WELL Health Technologies stock overvalued right now?
Based on GuruFocus' analysis, WELL Health Technologies (WHTCF) is currently considered Possible Value Trap. The stock's GF Value™ is $5.15, compared to a current price of $3.10 — trading 39.9% below its estimated fair value. The current Intrinsic Value: Projected FCF is $3.64 and 238.6% above the Healthcare Providers & Services industry median of 1.08. WELL Health Technologies' overall GF Score™ is 74/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Intrinsic Value: Projected FCF calculated?
Intrinsic Value: Projected FCF is calculated from a company's financial statements. For WELL Health Technologies (WHTCF), the current Intrinsic Value: Projected FCF is $3.64 as of Sep. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is WELL Health Technologies (WHTCF) Overvalued in 2026?
Based on GuruFocus' analysis, WELL Health Technologies stock appears to be undervalued.
The current stock price of $3.10 is trading 39.9% below its estimated GF Value™ of $5.15.
GuruFocus considers WELL Health Technologies to be Possible Value Trap.
Key valuation signals for WHTCF:
Intrinsic Value: Projected FCF: $3.64
GF Value™: $5.15 vs. price of $3.10 (39.9% below fair value)
Industry Position: 238.6% above the Healthcare Providers & Services median (#124 of 342)
No single metric tells the full story. See the WHTCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
WELL Health Technologies Corp is a practitioner-focused digital healthcare company. It has seven reportable segments that are grouped into three key business units: Canadian Patient Services that includes Primary and Specialized MyHealth; WELL Health USA Patient Services, which derives maximum revenue, includes Primary Circle Medica, Primary WISP, Specialized CRH Medical, and Specialized Provider Staffing; SaaS and Technology Services provides digital health and infrastructure solutions for healthcare providers, including Electronic MedicalRecords (EMRs), patient engagement and eReferral solutions, AI-enabled applications, billing and practice management services, and cybersecurity protection and data privacy solutions; and HEALWELL: AI and data sciences and healthcare software offerings.
74GF Score
Get the complete analysis for WHTCF
Intrinsic Value: Projected FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WHTCF has been successfully added to your 
